- Home
- BFRG vs ITOC Comparison
BFRG vs ITOC Comparison
Compare BFRG & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFRG | ITOC |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | China |
| Employees | 17 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 7.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFRG | ITOC |
|---|---|---|
| Price | $0.89 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.9M | 3.0M |
| Earning Date | 05-12-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $0.25 |
| 52 Week High | $2.12 | $0.65 |
Technical Indicators
Market Signals| Indicator | BFRG | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 50.27 | 37.17 |
| Support Level | $0.59 | N/A |
| Resistance Level | $1.20 | $0.38 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 26.66 | 11.88 |
Price Performance
Historical ComparisonAbout BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.